Clinic Directory — coming soon. Are you an Australian peptide clinic?Apply to be listed →
Independent · Australian · Education only — not medical adviceAboutEditorial standardsHow we review
HomeEncyclopediaAOD-9604

AOD-9604

Growth-hormone fragment

Not ARTG-approved

What it is

A fragment of growth hormone historically investigated in metabolic contexts.

What the evidence shows

Despite early metabolic interest, clinical trials did not establish it as an effective weight-loss medicine, and it is not registered as one.

Safety & reported risks

The marketing typically outpaces the evidence. As an unapproved product, sourcing and quality are the practical risks.

Status in Australia

Not ARTG-approved as a medicine. Marketed weight-loss framing is not supported by registration.

How it’s lawfully accessed

No approved medicine pathway. It is not on the ARTG for any weight-loss indication.

Related peptides

SemaglutideGLP-1 receptor agonistPrescription medicineTirzepatideDual GIP/GLP-1 agonistPrescription medicineAdipotideInvestigational metabolic peptide (FTPP)Investigational

Sources & further reading

This entry is general information about AOD-9604, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.

Written by The Peptides.au editorial team
Editorial review Checked against current TGA, ARTG and AHPRA public guidance
Last updated 1 June 2026

This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.